Lincoln National Corp Neogenomics Inc Transaction History

Lincoln National Corp

  • $3.11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022
SELL
$30.49 - $48.49 $304,900 - $484,900
-10,000 Closed
0 $0
Q3 2021

Nov 05, 2021
SELL
$41.66 - $52.52 $11,039 - $13,917
-265 Reduced 2.58%
10,000 $482,000
Q2 2021

Aug 13, 2021
BUY
$36.62 - $51.69 $375,904 - $530,597
10,265 New
10,265 $464,000

Others Institutions Holding NEO

# of Institutions
295
Shares Held
125M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email